BIOCON Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > biocon

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 64.8. According to RSI analysis, biocon is technically strong. 9.0 BIOCON RSI Chart
MACD (?) MACD: 4.92 and Signal Line: 4.3. According to MACD analysis, biocon is technically strong. 8.0 BIOCON MACD Chart
Simple Moving Average (?) According to simple moving average analysis, biocon is in a strong uptrend. Major support levels are 300.2125, 294.153, 243.4556. 10.0 BIOCON Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, biocon is in a strong uptrend. Major support levels are 301.6388, 292.6968, 249.8605. 10.0 BIOCON Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.971. According to bollinger bands, biocon is technically strong. 7.0 BIOCON Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 302.2684 and 297.1. Resistance level is 319.0. 6.5 BIOCON Fibonacci Retracement Chart
Average True Range (?) ATR: 9.7 NA BIOCON Average True Range Chart
Average Directional Index (?) ADX is 15.4 which means BIOCON is in a trading range and there is no trend. NA BIOCON Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
February 20, 2020
Open Price 305.95
High Price 319.0
Low Price 305.8
Close Price 315.05
Absolute Change 8.95
Percentage Change 2.92%
Weekly Change 2.61%
Monthly Change 7.03%
Yearly Change 95.8%
52-week high 319.0
52-week low 127.125
Corporate Actions
ExDate Purpose
July 18, 2019 DIV - RS 0.50 PER SH
July 18, 2019 DIV - RE 1 PER SH
June 12, 2019 BONUS 1:1
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.745
Confidence in Beta4.08%
Market Capital Rs. 6300.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 20 February 2020: Deliverable Quantity:1.58e+06 NA BIOCON Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 20 February 2020: Daily Volatility:0.3439 NA BIOCON Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 20 February 2020: PCR_OI:0.747 PCR:0.257 NA BIOCON PCR Chart
Option Pain (?) 20 February 2020: Max Pain:305.0 NA BIOCON Option Pain Chart
Premium (?) 20 February 2020 Premium: 1.05 Futures OI:12813300.0 NA BIOCON Premium Chart
Option_MAX_OI (?) 20 February 2020: Price:315.05 Put with maximum OI:300.0 Call with maximum OI:320.0 NA BIOCON Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
February 27, 2020 316.1 12813300.0 6154.0 6154.0 315.05
March 26, 2020 315.65 3013000.0 1060.0 1060.0 315.05
April 30, 2020 315.65 170200.0 19.0 19.0 315.05

Announcements

November 07, 2019 Reply to Clarification Sought BIOCON: The Exchange had sought clarification from Biocon Limited with respect to announcement dated 23-Oct-2019, regarding change in Director(s) of the company. On basis of above the Company was required to clarify following: 1. Confirmation from resigning independent director that there is no other material reasons other than provided. The response of the Company is attached.
November 07, 2019 Clarification BIOCON: The Exchange has sought clarification from Biocon Limited with respect to announcement dated 23-Oct-2019, regarding change in Director(s) of the company. On basis of above the Company is required to clarify following: 1. Confirmation from resigning independent director that there is no other material reasons other than provided. The response of the Company is awaited.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 06, 2020 January 23, 2020 Financial Results To consider and approve the financial results for the period ended December 31, 2019
October 04, 2019 October 23, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
See all Board Meetings

BIOCON is part of...

Index Weightage
CNXPHARMA NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play